Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma

BACKGROUND: Recurrent/ metastatic squamous cell carcinoma of head and neck (R/M SCCNH) is still a difficult-to-treat disease with poor clinical outcomes and limited treatment choices. In view of locoregional recurrent versus distant metastatic SCCHN, the therapeutic efficacy of cetuximab-containing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tien-Hua, Pan, Yi-Ying, Lee, Tsung-Lun, Wang, Ling-Wei, Tai, Shyh-Kuan, Chu, Pen-Yuan, Lo, Wen-Liang, Wu, Cheng-Hsien, Yang, Muh-Hwa, Chang, Peter Mu-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769042/
https://www.ncbi.nlm.nih.gov/pubmed/36539738
http://dx.doi.org/10.1186/s12885-022-10440-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769042/
https://www.ncbi.nlm.nih.gov/pubmed/36539738
http://dx.doi.org/10.1186/s12885-022-10440-7

Ejemplares similares